{
  "description": "Contact type for a Medicinal Product.",
  "_filename": "CodeSystem-medicinal-product-contact-type.json",
  "package_name": "hl7.fhir.uv.xver-r5.r4.r4",
  "date": "2021-01-05T09:01:24+10:00",
  "publisher": "Biomedical Research and Regulation",
  "jurisdiction": [ {
    "coding": [ {
      "code": "001",
      "system": "http://unstats.un.org/unsd/methods/m49/m49.htm",
      "display": "World"
    } ]
  } ],
  "content": "complete",
  "name": "ProductContactType",
  "type": null,
  "experimental": "false",
  "resourceType": "CodeSystem",
  "title": "Product Contact Type",
  "package_version": "0.0.1-snapshot-2",
  "extension": [ {
    "url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-standards-status",
    "valueCode": "trial-use"
  }, {
    "url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-fmm",
    "valueInteger": 1
  }, {
    "url": "http://hl7.org/fhir/StructureDefinition/package-source",
    "extension": [ {
      "url": "packageId",
      "valueId": "hl7.fhir.uv.xver-r5.r4"
    }, {
      "url": "version",
      "valueString": "0.0.1-snapshot-2"
    } ]
  }, {
    "url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-wg",
    "valueCode": "brr"
  } ],
  "status": "active",
  "id": "b45b4fd7-9e39-4368-846b-7e8aa5b167a4",
  "valueSet": "http://hl7.org/fhir/ValueSet/medicinal-product-contact-type",
  "kind": null,
  "url": "http://hl7.org/fhir/medicinal-product-contact-type",
  "concept": [ {
    "code": "ProposedMAH",
    "display": "Proposed Marketing Authorization Holder/Person",
    "definition": "Proposed Marketing Authorization Holder/Person"
  }, {
    "code": "ProcedureContactDuring",
    "display": "Person/Company authorised for Communication during procedure",
    "definition": "Person/Company authorised for Communication on behalf of the Applicant during the Procedure"
  }, {
    "code": "ProcedureContactAfter",
    "display": "Person/Company authorised for Communication after procedure",
    "definition": "Person/Company authorised for Communication between MAH and Authorities after Authorization"
  }, {
    "code": "QPPV",
    "display": "Qualified Person Responsible for Pharmacovigilance",
    "definition": "Qualified Person Responsible for Pharmacovigilance"
  }, {
    "code": "PVEnquiries",
    "display": "Pharmacovigilance Enquiry Information",
    "definition": "Pharmacovigilance Enquiry Information"
  } ],
  "caseSensitive": true,
  "version": "5.0.0",
  "contact": [ {
    "name": "Biomedical Research and Regulation",
    "telecom": [ {
      "value": "http://www.hl7.org/Special/committees/rcrim",
      "system": "url"
    } ]
  } ]
}